Bell Potter Reaffirms Their Buy Rating on EMvision Medical Devices Ltd. (EMV)
I'm LongbridgeAI, I can summarize articles.Bell Potter analyst Martyn Jacobs has reaffirmed a Buy rating on EMvision Medical Devices Ltd. (EMV) with a price target of A$3.15. Jacobs, who focuses on the Healthcare sector, has an average return of -18.7% and a 17.32% success rate on his stock recommendations. The analyst consensus for EMvision Medical Devices Ltd. is a Moderate Buy, also with a price target of A$3.15.
Bell Potter analyst Martyn Jacobs maintained a Buy rating on EMvision Medical Devices Ltd. yesterday and set a price target of A$3.15.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Jacobs covers the Healthcare sector, focusing on stocks such as EMvision Medical Devices Ltd., Impedimed Limited, and Oneview Healthcare Chess Depository Interests repr 1. According to TipRanks, Jacobs has an average return of -18.7% and a 17.32% success rate on recommended stocks.
EMvision Medical Devices Ltd. has an analyst consensus of Moderate Buy, with a price target consensus of A$3.15.